1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. LBX Pharmacy Chain Joint Stock Company
  6. Company
    603883   CNE1000023Q8

LBX PHARMACY CHAIN JOINT STOCK COMPANY

(603883)
  Report
End-of-day quote Shanghai Stock Exchange  -  05-23
36.18 CNY   +0.61%
04/28LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2021
CI
04/28LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
03/07LBX Pharmacy Chain Joint Stock Company singed an Asset Purchase Agreement to acquire a 71.9% stake in Hunan Huairen Great Health Industry Development Co., Ltd. from group of sellers for CNY 1.6 billion.
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
LBX Pharmacy Chain Joint Stock Company is a China-based company engaged in pharmaceutical retail chain operation. The Company involves in retailing drugs and other related products, including Chinese and Western medicines, prepared slices of Chinese crude drugs, health Chinese medicines, health equipment, healthy food, personal care products and life care products, among others. The Company also involves in wholesale and manufacture of drugs.

Number of employees : 29 164 people.
Sales per Business
20202021Delta
Retail12 078.1086.5%13 790.9087.9% +14.18%
Wholesale1 762.7612.6%1 785.4211.4% +1.29%
Other125.860.9%119.370.8% -5.16%
CNY in Million
Sales per region
20202021Delta
China13 966.70100%15 695.70100% +12.38%
CNY in Million
Managers
Name Title Age Since
Li Wang President 39 2019
Jing Yang Zhu Chief Financial Officer 46 2017
Li Tian Securities Representative - -
Shi Ni Feng Secretary 36 2019
Wen Ti Guan Vice President 37 2020
Members of the board
Name Title Age Since
Zi Long Xie Chairman 55 2019
Cheng Xiang Wang Chairman-Supervisory Board 44 -
Zhe Min Dan, Dr. Independent Director 49 2018
Jing Zhou Independent Director 57 2018
Wei De Huang Independent Director 50 2018
Liang Feng Wu Independent Director 53 2021
Bin Wu Director 61 -
Jian Tan Member-Supervisory Board 44 2018
Hao Rao Member-Supervisory Board 43 2018
Gan Huang Director 44 2019
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 448,601,481 204,062,252 45.5% 0 0.0% 45.5%
Shareholders
NameEquities%
Zi Long Xie 126,452,741 31.0%
EQT Partners AB 99,415,997 24.4%
Aegon-Industrial Fund Management Co., Ltd. 14,070,069 3.45%
Guotai Asset Management Co., Ltd. 13,769,088 3.37%
China Merchants Fund Management Co., Ltd. 12,798,591 3.14%
First Sentier Investors (Hong Kong) Ltd. 12,576,191 3.08%
Xiu Lan Chen 8,027,040 1.97%
JPMorgan Asset Management (Asia Pacific) Ltd. 7,654,394 1.88%
Abu Dhabi Investment Authority (Investment Management) 7,043,332 1.73%
Zhan Shi 6,068,420 1.49%
Holdings
NameEquities%Valuation
HUNAN DAJIAWEIKANG PHARMACEUTICAL INDUSTRY CO., LTD. 6,300,000 4.00% 15,675,849 USD
Company contact information
LBX Pharmacy Chain JSC
288 Xiangya Road
Kaifu District
Changsha, Hunan 410008

Phone : +86.731.84035189
Fax : +86.731.84035199
Web : http://www.lbxdrugs.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of LBX Pharmacy Chain Joint Stock Company